Netherlands· NL-84b8fe37f515

Salofalk 1,5 g Granu-Stix, granulaat met verlengde afgifte

A mesalazine product containing mesalazine, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC A07EC02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mesalazineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mesalazine is registered in 17 of 19 countries.

Countries holding a registration under ATC A07EC02 (mesalazine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search mesalazine products by name

Mesalazine · ATC A07EC02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mesalazine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.00 in Italy to $2.13 in Switzerland — a ×2.1 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mesalazine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

CH Switzerland$2.13
FR France$1.06
IT Italy$1.00

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MESALAZINE
Manufacturer: Medcor Pharmaceuticals B.V.
Country: Netherlands (NL)
ATC code: A07EC02
ATC class: Mesalazine
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
130657//100059

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

333 interactions on record for mesalazine.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mesalazine against other medicines How interaction checks work

Mesalazine · interactions on record

333 records

15 severe
95 moderate
223 info

Most severe, free to view

CidofovirJ05AB12severe
Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
SirolimusL01EG04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A07EC02

Mesalazine, as other registers publish it.

All mesalazine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a7f6b5d6-b81c-40b4-b96c-f77a084f94fd
GET /v1/drugs/a7f6b5d6-b81c-40b4-b96c-f77a084f94fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maagsapresistent granulaat",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100059_smpc.pdf",
  "strength": null,
  "atc_label": "Mesalazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130657",
  "excipients": [
    "ASPARTAAM (E 951)",
    "CARMELLOSE NATRIUM (E 466)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CITROENZUUR 0-WATER (E 330)",
    "COPOLYMEER VAN ETHYLACRYLAAT-METHYLMETHACRYLAAT (2:1) (E 1206)",
    "COPOLYMEER VAN METHACRYLZUUR-METHYLMETHACRYLAAT (1:1)",
    "HYPROMELLOSE (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "METHYLCELLULOSE (E 461)",
    "NONOXINOL",
    "POVIDON K 25 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROSE",
    "SILICIUMDIOXIDE (E 551)",
    "SIMETICON EMULSIE",
    "SORBINEZUUR (E 200)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TRIETHYLCITRAAT (E 1505)",
    "VANILLA CUSTARD FLAVOUR 75016-32 Givaudan-Roure"
  ],
  "substances": [
    "MESALAZINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130657.pdf",
  "authorised_at": "2023/07/31",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130657//100059",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about mesalazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console